+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-11-18Number of Pages: 86

Deep Brain Stimulation Devices Market for Parkinson's Disease - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Deep Brain Stimulation Devices Market: Snapshot

The rise in the global geriatric population, increasing number of patients suffering from Parkinson’s diseases (PD), and growing awareness about neurological movement disorders among patients have triggered the growth of the deep brain stimulation devices market. Globally, neurological disorders are one of the major causes of morality and accounts for approximately 12% of the deaths per annum. Of these, cerebrovascular diseases account for 85% deaths. Parkinson’s disease is the most common neurological disorders after Alzheimer’s disease. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness, and trouble with balance. Drug therapy is the most effective treatment option available to control PD in the initial stages. Though there are several stages of PD, surgical treatment using deep brain stimulation (DBS) devices is more frequently used to control symptoms of disease. DBS devices are an effective, clinically proven, and legally approved advanced treatment option for milk to serve PD.

The market for deep brain stimulation devices for Parkinson’s diseases is expected to grow at a robust rate of 11% during the forecast period of 2014 to 2020. The opportunity in the market is estimated to reach US$3.2 bn by the end of 2020. The growing burden of PD on healthcare systems, along with the uncertainty of economic conditions in some developed economies such as the U.S. and Europe has forced original equipment manufacturers (OEMs) to develop cost-effective devices for PD treatment.

North America to Maintain Most Prominent Demand for DBS Devices

Geographically, the global market for deep brain stimulation devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America currently serves the maximum demand for DBS devices for Pakistan’s disease, and is expected to maintain its leading position throughout the forecast period from 2014 to 2020, growing at a CAGR of 9.3% in terms of revenue. The region is expected to gain market share of 44.2% by the end of 2020. The key factors attributed to their leading position in the global market are high prevalence and incidence rate of Parkinson’s diseases in the region, aging population, demand for advanced deep brain stimulation devices and presence of high disposable income in the region.

The U.S. was the largest market for DBS devices for the treatment of Parkinson’s disease. According to the centers for Disease Control and Prevention, Pakistan’s disease is the 14th leading cause of death in the U.S. At present, approximately 1 million to 1.2 million people in the U.S. are suffering from Parkinson’s disease. The U.S. is a major R&D and technology center in the world and holds a key share in the healthcare industry with advanced technologies, presence of top companies, and relentless developments. Significant R&D activities are currently being undertaken by the U.S. Government to introduce innovative drugs and devices to help the society in disease management.

Canada is another prominent market for DBS devices for the treatment of Parkinson’s disease. According to the Parkinson’s Society Canada, approximately 100,000 people in Canada suffer from Parkinson’s disease. The disease affects nearly 1% of the population above 65 years of age and 2% of those about 70 years of age. Canada’s healthcare system has implemented a publicly funded insurance program wherein the costs are controlled by both hospitals and doctors. North America was followed by Europe as the widest market for the DBS devices for Parkinson’s diseases. The region is expected to contribute to 33.7% of the demand by the end of the forecast period of 2014–2020. Asia Pacific, though currently accounts for the third most prominent market for deep brain stimulation devices, it is expected to expand at a healthy CAGR of 8% during the forecast period of 2014–2020.

Some of the key players in global deep brain stimulation devices market are Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, Inc., and St. Jude Medical, Inc.

 

A rise in the global geriatric population, increasing number of patients suffering from Parkinson’s disease (PD) and growing awareness about neurological movement disorders among patients have triggered the growth of the deep brain stimulation devices market. Globally, neurological disorders are one of the major causes of mortality and account for approximately 12% of deaths per annum. Of these, cerebrovascular diseases account for 85% deaths. Parkinson’s disease is the most common neurological disorder after Alzheimer’s disease. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness and trouble with balance. Drug therapy is the most effective treatment option available to control PD in the initial stages; however, a large number of medicines are required to control the disease during its advanced stages. In the later stages of PD, surgical treatment using deep brain stimulation (DBS) devices is used to control symptoms of the disease. DBS devices are an effective, clinically proven and legally approved advanced treatment option for mild to severe PD. The market for DBS devices is expected to grow at a significant rate during the forecast period from 2014 to 2020. However, the high cost of the surgical procedure could hamper the growth of the market. The growing burden of PD on health care systems, along with the uncertainty of economic conditions in some developed economies such as the U.S. and Europe has forced original equipment manufacturers (OEMs) to develop cost-effective devices for PD treatment.

 

This market research report on DBS devices for the treatment of Parkinson’s disease provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of the market. The report discusses the market for deep brain stimulation devices for Parkinson’s disease based on prevalence of the disease and the use of these devices to treat PD in four geographical regions: North America, Europe, Asia Pacific and Rest of the World. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information on various segments and sub-segments that are included in the scope of the study. It also provides overall information and data analysis of the global market for deep brain stimulation devices for Parkinson’s disease with respect to market segments based on geography (i.e., region-wise and country-wise analyses).

 

The global market for DBS devices for Parkinson’s disease has been segmented with respect to geography. Market size estimates and forecasts for the period from 2012 to 2020 have been provided for each geographical region in terms of revenue (USD million), considering 2012 and 2013 as historical and base years, respectively. The CAGR (%) of each market segment for the forecast period from 2014 to 2020 has also been provided along with market size estimations. The market overview section provides a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global market for deep brain stimulation devices for the treatment of Parkinson’s disease. The section also covers opportunities, Porter’s five forces analysis as well as market attractiveness analysis and market share analysis of major players in the global DBS devices market.

 

A list of recommendations has been provided for new entrants and existing market players to help them establish a strong presence in the market and increase their share. The report also profiles the major players in the market for deep brain stimulation devices for Parkinson’s disease based on various attributes. The profiles include company overview, financial overview, business strategies, product portfolio and recent developments. Prominent players profiled in the report include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and Aleva Neurotherapeutics SA.

 

Global deep brain stimulation devices market for Parkinson’s disease is segmented as follows:

 

Deep Brain Stimulation Devices Market, By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Australia
    • New Zealand
    • Japan
    • India
    • China
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Brazil
    • Mexico
    • Rest of RoW


 
 
Back To Top